MedTrace Logo

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

NCT00328705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2008-02-13

No results posted yet for this study

Summary

This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.

Conditions

  • Heart Diseases

Interventions

DEVICE

Implantable Cardioverter Defibrillator

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Cole Hannon · Medtronic CRDM

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00328705 on ClinicalTrials.gov